Heart failure & cardiomyopathies

Prevalence of Heart Failure Phenotypes and Current Use of Therapies in Primary Care: Results from a Nationwide Study

ESC Heart FailPublished Cross-sectional study

Authors' conclusion

HFrEF is the most common phenotype of HF in primary care followed by recovered HFrEF and fundamental therapies are markedly underutilized.

Study context

Population
Patients with heart failure (HF) (ICPC-2 code K77) in primary care clinics in Denmarkecho data in 1042 (94%)
Participants
1,111 patients
Exposure
HF with Reduced Ejection Fraction (HFrEF) vs Recovered HFrEF vs HFmrEF or HFpEF
Outcome
Prevalence of HF phenotypes and current use of HF therapies
Methodological detailsnationwide, 148 primary care clinics, HF diagnosis made in a specialized setting in 95%
  • Nationwide
  • 148 primary care clinics
  • HF diagnosis made in a specialized setting in 95%

Main finding

As reported in the abstract

HF phenotype prevalence

Observational data: associations, not effects.

Further findings

OutcomeHFmrEF or HFpEFORP value
HF therapy prescription by phenotypeHFmrEF or HFpEF vs HFrEF or recovered HFrEF · point estimates across drug classes0.33 to 0.57all P-values < 0.05
ACEi, ARB or ARNI67%
Beta-blocker67%
MRA22%
SGLT2 inhibitor7.4%
Treatment in older vs young patients (HFrEF or recovered HFrEF), all drug classesPoint estimates across drug classes0.50 to 0.69all P-values < 0.05
  • HF therapy prescription by phenotype: HFrEF or recovered HFrEF ACEi, angiotensin receptor blocker (ARB) or angiotensin receptor neprilysin inhibitor (ARNI) 86% · Beta-blocker 82% · mineralocorticoid receptor antagonist (MRA) 38% · SGLT2 inhibitor 12%

Follow-up setting

Follow-up solely in primary care
64%
Solely primary care follow-up generally treated less vs specialized care; differences generally small
  • Setting available in 96%

Original publication

Prevalence of Heart Failure Phenotypes and Current Use of Therapies in Primary Care: Results from a Nationwide Study. ESC Heart Fail. Published 28 February 2023. doi:10.1002/ehf2.14324

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.